Investigation of the enhancement for Echinocandin B fermentation with methyl oleate from transcription level
Abstract Echinocandin B (ECB) is the key precursor compound of the antifungal drug Anidulafungin. The effects of the five precursor amino acids on ECB biosynthesis were firstly investigated. It showed that although L-threonine was a main compound of the hexapeptide scaffold of ECB, exogenous addition of L-threonine had no significant effect on the increase of ECB fermentation titer. Meanwhile, the ECB fermentation titer with methyl oleate showed two times higher than that of the other carbon sources. Transcription level analysis of the key genes for ECB biosynthesis indicated that the gene an655543 related to L-threonine biosynthesis showed higher value during the fermentation process, therefore, the exogenous addition of L-threonine had no obvious affection. Furthermore, it indicated that the transcription level of gene ecdA might be the main restriction factor for the ECB biosynthesis. The study provided the research foundation for the modification of the ECB producing strains in the following work..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Bioprocess and biosystems engineering - 46(2023), 7 vom: 30. Mai, Seite 1045-1052 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Niu, Kun [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Echinocandin B |
---|
Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
---|
doi: |
10.1007/s00449-023-02883-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR051785250 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR051785250 | ||
003 | DE-627 | ||
005 | 20230604064650.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230604s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00449-023-02883-4 |2 doi | |
035 | |a (DE-627)SPR051785250 | ||
035 | |a (SPR)s00449-023-02883-4-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Niu, Kun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Investigation of the enhancement for Echinocandin B fermentation with methyl oleate from transcription level |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
520 | |a Abstract Echinocandin B (ECB) is the key precursor compound of the antifungal drug Anidulafungin. The effects of the five precursor amino acids on ECB biosynthesis were firstly investigated. It showed that although L-threonine was a main compound of the hexapeptide scaffold of ECB, exogenous addition of L-threonine had no significant effect on the increase of ECB fermentation titer. Meanwhile, the ECB fermentation titer with methyl oleate showed two times higher than that of the other carbon sources. Transcription level analysis of the key genes for ECB biosynthesis indicated that the gene an655543 related to L-threonine biosynthesis showed higher value during the fermentation process, therefore, the exogenous addition of L-threonine had no obvious affection. Furthermore, it indicated that the transcription level of gene ecdA might be the main restriction factor for the ECB biosynthesis. The study provided the research foundation for the modification of the ECB producing strains in the following work. | ||
650 | 4 | |a Echinocandin B |7 (dpeaa)DE-He213 | |
650 | 4 | |a Methyl oleate |7 (dpeaa)DE-He213 | |
650 | 4 | |a Precursor amino acids |7 (dpeaa)DE-He213 | |
650 | 4 | |a Transcription level analysis |7 (dpeaa)DE-He213 | |
700 | 1 | |a Qi, Yu-Xin |4 aut | |
700 | 1 | |a Cai, Hong-Wei |4 aut | |
700 | 1 | |a Ye, Yi-Xin |4 aut | |
700 | 1 | |a Zhou, Hai-Yan |4 aut | |
700 | 1 | |a Liu, Xiao-Tian |4 aut | |
700 | 1 | |a Liu, Zhi-Qiang |0 (orcid)0000-0003-3259-6796 |4 aut | |
700 | 1 | |a Zheng, Yu-Guo |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioprocess and biosystems engineering |d Berlin : Springer, 1986 |g 46(2023), 7 vom: 30. Mai, Seite 1045-1052 |w (DE-627)SPR006131565 |w (DE-600)1476357-6 |x 1615-7605 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2023 |g number:7 |g day:30 |g month:05 |g pages:1045-1052 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00449-023-02883-4 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 46 |j 2023 |e 7 |b 30 |c 05 |h 1045-1052 |